Hepatitis B virus (HBV) dsRNA agent compositions and methods of use thereof
US11492623B2 · kind B2 · utility
1Cited by
41References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 2019 |
| Grant date | Nov 8, 2022 |
| Priority date | — |
| Expiry date | Aug 12, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/322
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to double stranded RNA agents targeting the hepatitis B virus (HBV) genome, and methods of using such agents to inhibit expression of one or more HBV genes and methods of treating subjects having an HBV infection or HBV-associated disorder, e.g., chronic hepatitis B infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.